Previous studies have observed that BRCA1 and BRCA2 pathogenic mutations carriers have 1.8 to 3.8-fold and 2.5 to 8.6-fold increased relative risk of developing PrCa by the age of ≤65 years old, respectively [15–19]. Here, BRCA2 is linked to pure red-cell aplasia.